Male infertility remains a complex clinical challenge, particularly for patients with oligozoospermia and azoospermia, where effective therapeutic options are limited. Emerging research suggests that retinoic acid signaling plays a critical role in regulating spermatogenesis, opening new avenues for potential treatment strategies.  

This virtual session will explore the biological role of retinoic acid in sperm development, review recent studies examining the impact of isotretinoin therapy on spermatogenesis, and discuss which patient populations may benefit from this emerging approach. Join us for an engaging discussion that bridges basic reproductive biology with evolving clinical applications, offering valuable insights for clinicians and researchers interested in advancing the management of male infertility.